A “reverse pharmacology” approach for developing an anti-malarial phytomedicine

<p>Abstract</p> <p>A “reverse pharmacology” approach to developing an anti-malarial phytomedicine was designed and implemented in Mali, resulting in a new standardized herbal anti-malarial after six years of research. The first step was to select a remedy for development, through a...

Full description

Bibliographic Details
Main Authors: Diakite Chiaka, Falquet Jacques, Graz Bertrand, Willcox Merlin L, Giani Sergio, Diallo Drissa
Format: Article
Language:English
Published: BMC 2011-03-01
Series:Malaria Journal
Online Access:http://www.malariajournal.com/content/10/S1/S8
id doaj-2d9bfcd3a25040339612f8a93a0ed152
record_format Article
spelling doaj-2d9bfcd3a25040339612f8a93a0ed1522020-11-24T21:18:28ZengBMCMalaria Journal1475-28752011-03-0110Suppl 1S810.1186/1475-2875-10-S1-S8A “reverse pharmacology” approach for developing an anti-malarial phytomedicineDiakite ChiakaFalquet JacquesGraz BertrandWillcox Merlin LGiani SergioDiallo Drissa<p>Abstract</p> <p>A “reverse pharmacology” approach to developing an anti-malarial phytomedicine was designed and implemented in Mali, resulting in a new standardized herbal anti-malarial after six years of research. The first step was to select a remedy for development, through a retrospective treatment-outcome study. The second step was a dose-escalating clinical trial that showed a dose-response phenomenon and helped select the safest and most efficacious dose. The third step was a randomized controlled trial to compare the phytomedicine to the standard first-line treatment. The last step was to identify active compounds which can be used as markers for standardization and quality control. This example of “reverse pharmacology” shows that a standardized phytomedicine can be developed faster and more cheaply than conventional drugs. Even if both approaches are not fully comparable, their efficiency in terms of public health and their complementarity should be thoroughly considered.</p> http://www.malariajournal.com/content/10/S1/S8
collection DOAJ
language English
format Article
sources DOAJ
author Diakite Chiaka
Falquet Jacques
Graz Bertrand
Willcox Merlin L
Giani Sergio
Diallo Drissa
spellingShingle Diakite Chiaka
Falquet Jacques
Graz Bertrand
Willcox Merlin L
Giani Sergio
Diallo Drissa
A “reverse pharmacology” approach for developing an anti-malarial phytomedicine
Malaria Journal
author_facet Diakite Chiaka
Falquet Jacques
Graz Bertrand
Willcox Merlin L
Giani Sergio
Diallo Drissa
author_sort Diakite Chiaka
title A “reverse pharmacology” approach for developing an anti-malarial phytomedicine
title_short A “reverse pharmacology” approach for developing an anti-malarial phytomedicine
title_full A “reverse pharmacology” approach for developing an anti-malarial phytomedicine
title_fullStr A “reverse pharmacology” approach for developing an anti-malarial phytomedicine
title_full_unstemmed A “reverse pharmacology” approach for developing an anti-malarial phytomedicine
title_sort “reverse pharmacology” approach for developing an anti-malarial phytomedicine
publisher BMC
series Malaria Journal
issn 1475-2875
publishDate 2011-03-01
description <p>Abstract</p> <p>A “reverse pharmacology” approach to developing an anti-malarial phytomedicine was designed and implemented in Mali, resulting in a new standardized herbal anti-malarial after six years of research. The first step was to select a remedy for development, through a retrospective treatment-outcome study. The second step was a dose-escalating clinical trial that showed a dose-response phenomenon and helped select the safest and most efficacious dose. The third step was a randomized controlled trial to compare the phytomedicine to the standard first-line treatment. The last step was to identify active compounds which can be used as markers for standardization and quality control. This example of “reverse pharmacology” shows that a standardized phytomedicine can be developed faster and more cheaply than conventional drugs. Even if both approaches are not fully comparable, their efficiency in terms of public health and their complementarity should be thoroughly considered.</p>
url http://www.malariajournal.com/content/10/S1/S8
work_keys_str_mv AT diakitechiaka areversepharmacologyapproachfordevelopinganantimalarialphytomedicine
AT falquetjacques areversepharmacologyapproachfordevelopinganantimalarialphytomedicine
AT grazbertrand areversepharmacologyapproachfordevelopinganantimalarialphytomedicine
AT willcoxmerlinl areversepharmacologyapproachfordevelopinganantimalarialphytomedicine
AT gianisergio areversepharmacologyapproachfordevelopinganantimalarialphytomedicine
AT diallodrissa areversepharmacologyapproachfordevelopinganantimalarialphytomedicine
AT diakitechiaka reversepharmacologyapproachfordevelopinganantimalarialphytomedicine
AT falquetjacques reversepharmacologyapproachfordevelopinganantimalarialphytomedicine
AT grazbertrand reversepharmacologyapproachfordevelopinganantimalarialphytomedicine
AT willcoxmerlinl reversepharmacologyapproachfordevelopinganantimalarialphytomedicine
AT gianisergio reversepharmacologyapproachfordevelopinganantimalarialphytomedicine
AT diallodrissa reversepharmacologyapproachfordevelopinganantimalarialphytomedicine
_version_ 1726008925721985024